ExlService Holdings, Inc. research snapshot
EXLS AI stock analysis as of the August 3, 2026 data cutoff reads ExlService Holdings as a data and AI services company whose growth re-accelerated through the first half of 2026. The stock traded at $34.60 on August 3, 2026 at 11:38 AM EDT, up 0.67 or 1.97% from the $33.93 close on July 31, within a $33.97 to $35.24 day range, carrying a market capitalization near $5.25 billion, consistent with $34.60 times 151.7 million shares outstanding. Q2 2026 revenue rose 15.6% to $594.8 million, adjusted diluted EPS rose 22.3% to $0.59, data and AI-led revenue grew 30% and now represents 61% of revenue, and management raised full-year guidance to $2.390 billion to $2.415 billion of revenue and $2.25 to $2.29 of adjusted diluted EPS. On August 3, 2026, the company completed its $310 million acquisition of iMerit, adding foundation model training, evaluation, and reinforcement learning capabilities. The stock sits above its 20-day, 50-day, 100-day, and 200-day moving averages of roughly $29.25, $28.53, $29.48, and $33.95, with 14-day RSI near 68.8, strong but approaching overbought. The AI score sits at 76 out of 100 with a rating of growth re-accelerating at a reasonable forward multiple, because the data and AI-led mix, client wins, and guidance raise support the thesis while integration and enterprise AI adoption risks remain. This page is informational only and is not investment advice.
Current price
$34.60 at the August 3, 2026, 11:38 AM EDT reading, up 0.67 or 1.97% from the $33.93 July 31 close, within a $33.97 to $35.24 day range after opening at $34.99
Market cap
$5.25 billion
AI score
76 / 100
Rating
Growth re-accelerating as data and AI-led mix expands at a reasonable forward multiple
Trend status
Uptrend above the 20-day, 50-day, 100-day, and 200-day moving averages after the Q2 2026 report and iMerit completion
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | EXL is a global data and AI services company helping insurance, healthcare and life sciences, banking and capital markets, and international clients run digital operations, analytics, and AI-enabled services, with TTM revenue near $2.24 billion, TTM net income near $250 million, and data and AI-led revenue now 61% of total. | Medium-high |
| Moat | The moat comes from deep domain knowledge in insurance and healthcare workflows, 25% of client revenue touching proprietary IP, embedded operations that create switching costs, regulatory and compliance expertise in regulated industries, a global delivery footprint of roughly 68,000 employees, and now iMerit capabilities for model training, evaluation, and reinforcement learning. | Medium |
| Management | Co-founder, Chairman, and CEO Rohit Kapoor has led since 2002, executing a long-term shift from BPO to analytics to data and AI services, with 17 new client wins in Q2 2026, a 30% data and AI-led growth rate, H1 buybacks of 5.8 million shares for $179 million, and a raised 2026 guidance on revenue and adjusted EPS. | Medium-high |
| Financial trend | Revenue grew 13.6% in FY2025 to $2.088 billion and 13.6% over the trailing twelve months to about $2.24 billion. Q2 2026 revenue rose 15.6% to $594.8 million, adjusted EPS rose 22.3% to $0.59, adjusted operating margin held at 19.7%, and management raised full-year guidance to $2.390 billion to $2.415 billion of revenue and $2.25 to $2.29 of adjusted EPS. | High |
| Valuation | At $34.60, EXL trades near 21.9x trailing EPS, about 15.1x FY2026 forward adjusted EPS, near 19x trailing free cash flow, about 2.3x revenue, and at a PEG near 1.0, with a 5.2% to 5.4% free cash flow yield and no dividend. The multiple sits between the 5-year average and the peak, reflecting a re-rating as growth accelerated. | Medium |
| Technical trend | EXLS traded at $34.60 on August 3, 2026 at 11:38 AM EDT, above its 20-day, 50-day, 100-day, and 200-day moving averages of roughly $29.25, $28.53, $29.48, and $33.95, with 14-day RSI near 68.8 on Barchart and 68.23 on StockAnalysis.com, strong but approaching overbought after a rebound from the $24.85 low. | Medium |
| Risk level | The thesis can fail if enterprise AI spending shifts back to infrastructure and models rather than the application and enablement layer, client budgets tighten, the iMerit acquisition dilutes or disrupts integration, competition intensifies pricing pressure, margin compression continues, the stock fails to hold above the 200-day moving average near $33.95, or FX swings reduce growth. | Medium-high |
| AI confidence | High for descriptive facts and cross-checked math that matched across StockAnalysis.com, Barchart, SEC EDGAR XBRL, the Q2 2026 earnings release, the Q2 2026 Form 10-Q, and the Q2 2026 earnings call. Lower for forward return estimates because enterprise AI adoption, integration, competition, and margins are uncertain. | High data confidence |
| Investment certainty | Medium certainty. The page gives a research framework and scenario ranges, not a buy or sell instruction. | Medium |
EXLS AI stock forecast
The EXLS AI stock forecast uses scenario math around the $34.60 August 3, 2026 reading and the FY2026 adjusted EPS consensus of $2.29. The three-scenario framework produced a bearish area near $32, a base area near $51, and a bullish area near $75 over three years, using adjusted EPS growth of 5%, 12%, and 18% and exit multiples of 12x, 16x, and 20x, computed with the financial rigor tool. These are scenarios, not price commitments.
$68 to $82
More likely if data and AI-led revenue keeps growing near 30%, iMerit integrates cleanly and contributes the expected revenue, client wins and win rates stay elevated, adjusted operating margin expands despite second-half investment, and the market keeps the stock near 18x to 20x forward adjusted EPS.
$46 to $58
More likely if EXL compounds adjusted EPS at a high single digit to mid-teens rate, delivers the $2.25 to $2.29 guidance path, keeps revenue growth in the mid-teens, and the stock holds near 14x to 16x forward adjusted EPS.
$28 to $36
More likely if enterprise AI adoption slows, client budgets tighten, iMerit proves dilutive or slow to integrate, competition intensifies pricing pressure, margins compress, growth decelerates toward high single digits, or the multiple compresses toward the 12x area.
EXLS AI technical analysis
EXLS AI technical analysis is positive as of the August 3, 2026 data cutoff. The stock traded at $34.60 at 11:38 AM EDT, up 0.67 or 1.97% from the $33.93 July 31 close, above its 20-day, 50-day, 100-day, and 200-day moving averages of roughly $29.25, $28.53, $29.48, and $33.95, with 14-day RSI near 68.8. After falling from a 52-week high of $45.08 to a low of $24.85, the stock rebounded on the Q2 2026 report and the iMerit completion, reclaiming the 200-day moving average. Because this page does not fetch request-time chart data, confirm all levels in a charting tool before use.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $34.60 | StockAnalysis.com real-time quote at the August 3, 2026, 11:38 AM EDT reading, up 0.67 or 1.97% from the $33.93 July 31 close within a $33.97 to $35.24 day range after opening at $34.99. |
| 52-week high | $45.08 | Former peak from early 2026. A recovery toward this level is possible only if growth and margin execution stay strong. |
| 52-week low | $24.85 | The March 2026 low. A break below this level would re-open the prior downtrend. |
| 200-day moving average | $33.95 | Just below the current price. The stock reclaimed this level after the Q2 2026 report, a meaningful trend-change signal if it holds. |
| 100-day moving average | $29.48 | Barchart reported the 100-day moving average near $29.48 on August 3, 2026, well below price and confirming the medium-term recovery. |
| 20-day moving average | $29.25 | Barchart placed the 20-day moving average near $29.25, a natural first pullback support zone. |
| 50-day moving average | $28.53 | Barchart and StockAnalysis.com both reported the 50-day moving average near $28.53 on August 3, 2026. |
| Near support | $33.50 to $34.00 | The 200-day moving average near $33.95 and the $33.50 area form the first support zone under the current price. |
| Next support | $29.00 to $29.50 | The 20-day moving average near $29.25 and the 100-day near $29.48 cluster as a deeper support zone. |
| Resistance | $35.00 to $36.00 | The day high of $35.24 and the round $35 to $36 area are the near-term resistance before the recovery can extend. |
| Momentum | RSI near 68.8, ADX near 22.7 | 14-day RSI was near 68.83 on Barchart and 68.23 on StockAnalysis.com, strong but approaching overbought after the fast rebound, and 14-day ADX near 22.7 with +DI near 45.7 well above -DI near 13.6 confirmed the uptrend. |
| Volume | About 2.5 million average shares | Barchart listed 20-day average volume near 2.49 million shares and StockAnalysis.com near 2.49 million on August 3, 2026, with the 5-day average near 3.98 million, confirming accumulation on the rebound. |
| Volatility | Elevated | Barchart reported 14-day historic volatility near 79.06% and 20-day near 71.62%, so position sizing should account for wide daily ranges around earnings and AI news. |
| Invalidation | Close back below $33.95 | A decisive close back below the 200-day moving average near $33.95 would weaken the recovery; a close below the 20-day near $29.25 would turn the setup bearish. |
EXLS AI trading strategy
The EXLS AI trading strategy is a rules-based research framework for trading and watching the data and AI services recovery. It is not personal advice and should be paired with fresh chart data, filings, position sizing, and a defined invalidation level.
Watch for EXLS to hold above the 200-day moving average near $33.95 and to build volume on a push toward the $35 to $36 resistance zone, with the 20-day and 50-day moving averages rising underneath.
A daily close back below the 200-day moving average near $33.95 or a failure at resistance should trigger a stop and review.
If EXLS pulls back toward the $29.00 to $29.50 support cluster formed by the 20-day and 100-day moving averages without new fundamental damage, compare the price reaction with Q2 and Q3 results, iMerit integration, and data and AI-led growth before acting.
Do not average down without a maximum loss rule because enterprise AI adoption headlines can turn a support zone into a value trap.
Track data and AI-led revenue growth, total operations growth, client win counts, iMerit revenue contribution and integration, adjusted operating margin, buyback pace, and the 2026 guidance path.
Reduce confidence if growth slows toward high single digits, margins compress more than guided, or iMerit proves dilutive or slow to integrate.
Investment research summary
EXL helps insurance, healthcare and life sciences, banking and capital markets, and international clients run digital operations, analytics, and AI-enabled services. Clients pay for measurable outcomes such as lower claims processing costs, faster underwriting, payment integrity savings, and AI-driven productivity, with long-term client relationships and data and AI-led revenue now 61% of total.
Competitive advantages come from deep domain knowledge in insurance and healthcare workflows, 25% of client revenue touching proprietary IP, embedded operations that create switching costs, compliance and regulatory expertise in regulated industries, a roughly 68,000-person global delivery footprint, and iMerit capabilities for model training, evaluation, and reinforcement learning.
The thesis fails if enterprise AI spending stays concentrated in infrastructure and models rather than the application and enablement layer, client budgets tighten, the iMerit acquisition proves dilutive or culturally difficult to integrate, competition from Genpact, Cognizant, Infosys, and Accenture intensifies pricing pressure, margin compression from front-end sales and AI investment continues, or FX swings reduce growth.
Co-founder, Chairman, and CEO Rohit Kapoor has led the company since 2002, demonstrating steady strategic evolution from BPO to analytics to data and AI services. Q2 2026 delivered 17 new client wins, 30% data and AI-led growth, a 19.7% adjusted operating margin, H1 buybacks of 5.8 million shares for $179 million, and a raised 2026 guidance. The iMerit acquisition adds founder Radha Ramaswami Basu to the executive committee.
EXL sits at the intersection of BPO and enterprise AI enablement, where Gartner projects open-source GenAI models will underpin more than 50% of enterprise use cases by 2028. Data and AI-led revenue grew 18% in Q3 2025, 21% in Q4 2025, 28% in Q1 2026, and 30% in Q2 2026, while total operations revenue grew about 10%, suggesting the BPO base is evolving rather than shrinking.
At $34.60, the forward P/E near 15.1x on FY2026 adjusted EPS of $2.29, a P/FCF near 19x, and a PEG near 1.0 are moderate for a business growing revenue in the mid-teens. The margin of safety is thinner than before the Q2 2026 report because the stock rebounded roughly 26% off the low, and continued upside depends on sustaining double-digit growth and executing the iMerit integration.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| EXLS price | $34.60 at the August 3, 2026, 11:38 AM EDT reading, up 0.67 or 1.97% from the $33.93 July 31 close, within a $33.97 to $35.24 day range, after opening at $34.99 | StockAnalysis.com real-time quote | August 3, 2026 |
| Market capitalization | $5.25 billion, reported by StockAnalysis.com and consistent with $34.60 x 151.7 million shares outstanding | StockAnalysis.com quote and share statistics | August 3, 2026 |
| Q2 2026 revenue | $594.8 million, up 15.6% on a reported basis and 15.9% on a constant currency basis, up 4.3% sequentially | EXL Q2 2026 earnings release | July 28, 2026 |
| Q2 2026 EPS | Adjusted diluted EPS of $0.59, up 22.3% from $0.49, and GAAP diluted EPS of $0.42, up 4.9% from $0.40 | EXL Q2 2026 earnings release | July 28, 2026 |
| Q2 2026 margins | Gross margin of 38.0%, operating margin of 14.7%, and adjusted operating margin of 19.7% | EXL Q2 2026 earnings release | July 28, 2026 |
| Q2 2026 segment revenue | Insurance $197.8 million up 14.9%, Healthcare and Life Sciences $158.0 million up 22%, Banking, Capital Markets and Diversified Industries $133.9 million up 10.7%, and International Growth Markets $105.1 million up 16.3% | EXL Q2 2026 earnings release and Q2 2026 earnings call | July 29, 2026 |
| Data and AI-led growth | Data and AI-led revenue grew 30% year over year in Q2 2026 and represents 61% of revenue, after growth of 18% in Q3 2025, 21% in Q4 2025, and 28% in Q1 2026; digital operations revenue fell about 1.5% by design as AI-enabled work moves into the data and AI-led category, while total operations revenue grew about 10% | EXL Q2 2026 earnings call | July 29, 2026 |
| New client wins | 17 new clients won in Q2 2026 | EXL Q2 2026 earnings release | July 28, 2026 |
| 2026 guidance raised | Revenue of $2.390 billion to $2.415 billion, up 14% to 16% reported and 13% to 14% organic constant currency, including $28 million to $32 million from iMerit, and adjusted diluted EPS of $2.25 to $2.29, up 16% to 18%, including a marginal $0.01 dilution from iMerit | EXL Q2 2026 earnings release and Q2 2026 earnings call | July 29, 2026 |
| First-half 2026 results | Revenue of $1.165 billion, up 14.7%, adjusted operating margin of 20.1% up 20 basis points, and adjusted EPS of $1.17, up 21.3% | EXL Q2 2026 earnings call | July 29, 2026 |
| Buybacks and capital returns | Repurchased 5.8 million shares at an average price of $30.90 for $179 million in the first half of 2026, including 4.15 million shares under an accelerated share repurchase at $30.10; shares outstanding fell 3.73% year over year | EXL Q2 2026 earnings call and StockAnalysis.com statistics | July 29, 2026 |
| iMerit acquisition | Completed the acquisition of iMerit on August 3, 2026 for up to $310 million; iMerit adds AI model training, evaluation, and reinforcement learning, founder and CEO Radha Ramaswami Basu joins EXL as Executive Vice President and Head of iMerit on the executive committee; $28 million to $32 million of revenue expected for the rest of 2026 | EXL iMerit completion press release and Q2 2026 earnings call | August 3, 2026 |
| TTM revenue | $2.24 billion over the trailing twelve months ended June 30, 2026, up 13.6%, matching StockAnalysis.com financials and SEC EDGAR XBRL | StockAnalysis.com financials and SEC EDGAR XBRL | August 3, 2026 |
| TTM net income and EPS | Net income near $250 million and EPS near $1.58 over the trailing twelve months, up 5.8% and 8.7% respectively | StockAnalysis.com quote and statistics | August 3, 2026 |
| Cash and cash equivalents | $126.722 million as of June 30, 2026, matching SEC EDGAR XBRL from the Q2 2026 Form 10-Q | EXL Q2 2026 Form 10-Q and SEC EDGAR XBRL | August 3, 2026 |
| Short-term investments | $157.102 million as of June 30, 2026 | EXL Q2 2026 Form 10-Q | August 3, 2026 |
| Cash plus short-term investments | $283.824 million as of June 30, 2026, which the Q2 2026 earnings call rounds to about $284 million | EXL Q2 2026 Form 10-Q and Q2 2026 earnings call | August 3, 2026 |
| Borrowings and net debt | Current portion of long-term borrowings of $381.155 million and no long-term borrowings as of June 30, 2026, giving a net debt position near $97 million against cash plus short-term investments of about $284 million, per the Q2 2026 earnings call | EXL Q2 2026 Form 10-Q and Q2 2026 earnings call | August 3, 2026 |
| Total assets and equity | Total assets of $1.7479 billion and total stockholders equity of $866.242 million as of June 30, 2026, matching the Q2 2026 Form 10-Q | EXL Q2 2026 Form 10-Q | August 3, 2026 |
| Shares outstanding | 151,745,072 shares outstanding as of June 30, 2026, per the Q2 2026 Form 10-Q cover; StockAnalysis.com lists 151.61 million | EXL Q2 2026 Form 10-Q and StockAnalysis.com statistics | August 3, 2026 |
| Valuation check | 21.95x trailing PE, 5.94x book value, 18.70x free cash flow, 2.30x revenue, PEG 1.01, EV/EBITDA 13.60, with market cap math of $34.60 x 151.745 million shares equal to $5.25 billion verified with the financial rigor tool | StockAnalysis.com statistics | August 3, 2026 |
| Forward valuation | 14.53x forward PE on the statistics page versus about 15.11x computed as $34.60 divided by the $2.29 FY2026 adjusted EPS consensus | StockAnalysis.com statistics and forecast | August 3, 2026 |
| Analyst consensus | Strong Buy with an average target of $44.38 across 9 analysts, low $39 and high $48, median $45 | StockAnalysis.com forecast | July 31, 2026 |
| Analyst rating mix, July 2026 | 6 Strong Buy, 3 Buy, 0 Hold, 0 Sell out of 9 analysts | StockAnalysis.com forecast recommendation trends | July 31, 2026 |
| Recent analyst target updates | J.P. Morgan $43 to $48 on July 30, Barrington $40 to $43 on July 30, Baird upgraded to Outperform with $35 to $45 on July 30, Needham $40 to $45 on July 29, Jefferies reiterated Buy at $39 on July 31, and TD Cowen lowered $45 to $39 with a Buy rating about a month earlier | StockAnalysis.com forecast and TipRanks news feed | July 31, 2026 |
| Short interest | 12.02 million shares short, 7.93% of shares outstanding, 8.81% of float, 3.98 days to cover | StockAnalysis.com statistics short selling | August 3, 2026 |
| Trailing free cash flow | Operating cash flow of $327.71 million, capital expenditures of $52.67 million, and free cash flow of $275.04 million over the trailing twelve months, with FCF per share of $1.81 and a 5.35% FCF yield | StockAnalysis.com cash flow statement and statistics | August 3, 2026 |
| Margins and returns | Gross margin 38.51%, operating margin 14.84%, profit margin 11.17%, EBITDA margin 17.58%, ROE 25.94%, ROIC 24.09%, and ROCE 31.92% over the trailing twelve months | StockAnalysis.com statistics | August 3, 2026 |
| 2026 and 2027 consensus estimates | FY2026 revenue estimate $2.41 billion with adjusted EPS $2.29, FY2027 revenue $2.69 billion with adjusted EPS $2.60, 3-year revenue growth forecast 12.94%, and 3-year EPS growth forecast 15.26% | StockAnalysis.com forecast financial forecast | July 31, 2026 |
| 52-week range and performance | 52-week range $24.85 to $45.08, down about 19% over the trailing 52 weeks and about 18.9% year to date, beta 0.84 | StockAnalysis.com quote and statistics | August 3, 2026 |
| Technical snapshot | 5-day SMA near $33.84, 20-day SMA near $29.25, 50-day SMA near $28.53, 100-day SMA near $29.48, 200-day SMA near $33.95, 14-day RSI near 68.83 on Barchart and 68.23 on StockAnalysis.com, 14-day ADX near 22.7, and 20-day average volume near 2.49 million shares | Barchart and StockAnalysis.com technical snapshots | August 3, 2026 |
This EXLS AI stock analysis is an informational research tool, not investment advice, a recommendation, or a promise of future return. Forecast ranges are scenarios based on available filings, quote snapshots, and third-party data as of the stated cutoff date. They may be wrong, incomplete, or outdated after new earnings, acquisitions, market moves, or macro conditions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
